Clinical trial of a new corticosteroid in some aspecific inflammatory ocular diseases: dexamethasone 21- (pyridine-4-carboxylate)
Balestrazzi, E.; Scorcia, G.; Ranieri, G.
Annali di Ottalmologia E Clinica Oculistica 97(1): 15-22
1971
ISSN/ISBN: 0003-4665 PMID: 5122645 Document Number: 38272
Document emailed within 1 workday
Related Documents
Chaĭka, L.A.; Povolotskaia, V.A. 1995: The effect of local corticosteroid therapy on ophthalmic tonus and ocular hydro- and hemodynamics in experimental inflammatory pathology Eksperimental'naia i Klinicheskaia Farmakologiia 58(3): 62-64Stenström, C.H.; Arge, B.; Sundbom, A. 1997: Home exercise and compliance in inflammatory rheumatic diseases--a prospective clinical trial Journal of Rheumatology 24(3): 470-476
Rossano, C.; Testasecca, D.; Giugliano, F.; Memé, E. 1974: New administration technic for 7,2-hydroxy-3-(N-hydroxyethyl-N-methylamino)-propyl-1,3-dimethylxanthine, pyridine-3-carboxylate (Complamine). Shock-dose arterioclysis Minerva Anestesiologica 40(3): 124-131
Napoli, A.; Alderuccio, B.; Nannetti, A. 1977: Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial La Clinica Terapeutica 83(5): 541-547
Vyshegurov, I.K.; Anikhovskaia, I.A.; Batmanov, I.E.; Iakovlev, M.I. 2007: Intestinal endotoxin in the pathogenesis of ocular inflammatory diseases and the antiendoxin constituent of its treatment Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 12-14
Ueda, M.; Masui, M.; Kawakami, M.; Matsunaga, K.; Gemba, T.; Ninomiya, M.; Nakano, A.; Torii, M.; Adachi, I.; Ito, H. 1993: Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats Arzneimittel-Forschung 43(12): 1291-1303
Gemba, T.; Ninomiya, M.; Matsunaga, K.; Ueda, M. 1993: Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 265(1): 463-467
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Alpermann, H.G.; Ruschig, H.; Meixner, W. 1972: 4-(2-chloro-3-methylphenylamine)-3-thiophene-carboxylate, a highly active anti-inflammatory drug Arzneimittel-Forschung 22(12): 2146-2147
Terblanche, A.J.; Green, R.J.; Rheeder, P.; Wittenberg, D.F. 2008: Adjunctive corticosteroid treatment of clinical Pneumocystis jiroveci pneumonia in infants less than 18 months of age--a randomised controlled trial South African Medical Journal 98(4): 287-290
Scuderi, G.; Sborgia, C.; Sborgia, G.; Manno, M.L. 1975: Study of pyridine nucleotides in ocular tissues. II. Concentration of NAD and NADH in crystalline lenses of rabbits of various ages Bollettino della Societa Italiana di Biologia Sperimentale 51(20): 1364-1365
Tessler, H.H. 2002: Ocular inflammatory disease: use of topical and systemic anti-inflammatory agents Managed Care 11(1 Suppl): 12-15; Discussion: 24-27
Eberl, R. 1980: Long-term treatment of inflammatory and degenerative joint diseases with piroxicam - a field trial Wiener Medizinische Wochenschrift 130(Special Issue): 36-42
Del Rosso, J.Q.; Kircik, L.H. 2013: The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream Journal of Drugs in Dermatology: Jdd 12(2): S5
Doroshenko, I.A.; Bagirova, V.V.; Savinova, N.A. 1987: Various aspects of the differential diagnosis of a pulmonary syndrome in systemic scleroderma and chronic aspecific lung diseases Terapevticheskii Arkhiv 59(4): 92-97
Teodorescu, C.; Teodorescu, I.; Raneti, C.; Dumitrica, D.M.; Stefan, C. 2008: The antitoxoplasma gondii antibodies incidence to the different ocular diseases patients cases of human ocular toxoplasmosis infections in Romania Oftalmologia 52(4): 88-94
Kozlovskaia, V.E.; Grishanova, A.I.; Mishin, V.M.; Liakhovich, V.V. 1992: The effect of pyridine and pyridine-N-oxide on the monooxygenase system of rat liver microsomes Biokhimiia 57(10): 1592-1596
Spinner, D.; Walter, J.; Vazquez-Gragg, M.; Bloise, T.; Stafford-Smith, M.; Faulkner, E.; Taekman, J. 2011: Php74 Clinical Trial Learning Curves Affect Outcomes Measurement, Patient Safety and Trial Success: Contributing Factors and a Potential Solution in Clinical Trial Simulation Value in Health 14(3): A24-A25
Mamiliaev, R.M.; Shergina, E.A.; Matsulevich, T.V. 1992: Complex clinico-radiographic and functional diagnosis of bronchial patency impairment in patients with tuberculosis and chronic aspecific lung diseases Problemy Tuberkuleza 1992(3-4): 47-49
Nantka-Namirski, P.; Balicki, R. 1974: Dipyridyls. 3. Reactions of pyridine-3- and pyridine 4-aldehydes with malononitrile Acta Poloniae Pharmaceutica 31(3): 271-278